Latest News and Events
Filter by
Selections
November 8, 2019
Arrowhead and Collaborator Janssen Present Phase 2 Clinical Data for Investigational Hepatitis B Regimens at The Liver Meeting® 2019
Read MoreOctober 31, 2019
Arrowhead Pharmaceuticals Presents Preclinical Data on ARO-ENaC at the North American Cystic Fibrosis Conference
Read MoreOctober 18, 2019
Arrowhead Pharmaceuticals Hosts R&D Day on Emerging Pipeline of RNAi Therapeutics
Read MoreOctober 2, 2019
Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics
Read MoreSeptember 30, 2019
Arrowhead Pharmaceuticals to Participate in Upcoming October 2019 Conferences
Read MoreSeptember 20, 2019
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
Read MoreSeptember 16, 2019
Arrowhead Pharmaceuticals Presents Initial Top-Line Clinical Data and Preclinical Data on RNAi Candidates ARO-APOC3 and ARO-ANG3
Read MoreAugust 30, 2019
Arrowhead Pharmaceuticals to Participate in Upcoming September 2019 Conferences
Read MoreAugust 28, 2019